Vidya Gopalakrishnan
Vidya Gopalakrishnan
MD Anderson Cancer Center, Johns Hopkins University, University of Pittsburgh
Подтвержден адрес электронной почты в домене mdanderson.org
Название
Процитировано
Процитировано
Год
The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance
KC Schreck, P Taylor, L Marchionni, V Gopalakrishnan, EE Bar, N Gaiano, ...
Clinical cancer research 16 (24), 6060-6070, 2010
1742010
Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation
X Su, V Gopalakrishnan, D Stearns, K Aldape, FF Lang, G Fuller, ...
Molecular and cellular biology 26 (5), 1666-1678, 2006
1672006
Valproic acid induces p21 and topoisomerase-II (α/β) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines
CM Das, D Aguilera, H Vasquez, P Prasad, M Zhang, JE Wolff, ...
Journal of neuro-oncology 85 (2), 159-170, 2007
1172007
Conversion of myoblasts to physiologically active neuronal phenotype
Y Watanabe, S Kameoka, V Gopalakrishnan, KD Aldape, ZZ Pan, ...
Genes & development 18 (8), 889-900, 2004
1072004
E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication
V Gopalakrishnan, SA Khan
Proceedings of the National Academy of Sciences 91 (20), 9597, 1994
861994
Redundant control of rereplication in fission yeast
V Gopalakrishnan, P Simancek, C Houchens, HA Snaith, MG Frattini, ...
Proceedings of the National Academy of Sciences 98 (23), 13114, 2001
772001
MLL4 is required to maintain broad H3K4me3 peaks and super-enhancers at tumor suppressor genes
SS Dhar, D Zhao, T Lin, B Gu, K Pal, SJ Wu, H Alam, J Lv, K Yun, ...
Molecular cell 70 (5), 825-841. e6, 2018
662018
Measuring cytotoxicity: a new perspective on LC50
M ZHANG, D AGUILERA, C DAS, H VASQUEZ, P ZAGE, ...
Anticancer research 27 (1A), 35-38, 2007
612007
REST and the RESTless: in stem cells and beyond
V Gopalakrishnan
Future neurology 4 (3), 317-329, 2009
592009
Influence of valproic acid on outcome of high-grade gliomas in children
A MASOUDI, M ELOPRE, E AMINI, ME NAGEL, JL ATER, ...
Anticancer research 28 (4C), 2437-2442, 2008
582008
REST is a novel prognostic factor and therapeutic target for medulloblastoma
P Taylor, J Fangusaro, V Rajaram, S Goldman, IB Helenowski, ...
Molecular cancer therapeutics 11 (8), 1713-1723, 2012
492012
Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCFβ‐TRCP in neuroblastoma cells
A Singh, C Rokes, M Gireud, S Fletcher, J Baumgartner, G Fuller, ...
Cancer, 2011
472011
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL
DG Aguilera, CM Das, ND Sinnappah-Kang, C Joyce, PH Taylor, S Wen, ...
Journal of neuro-oncology 93 (3), 303-318, 2009
462009
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation
CM Das, P Taylor, M Gireud, A Singh, D Lee, G Fuller, L Ji, J Fangusaro, ...
Oncogene, 2012
392012
Regulation of USP37 expression by REST-associated G9a-dependent histone methylation
THW Dobson, RJ Hatcher, J Swaminathan, CM Das, S Shaik, RH Tao, ...
Molecular Cancer Research 15 (8), 1073-1084, 2017
202017
Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial
DI Sandberg, M Rytting, W Zaky, M Kerr, L Ketonen, U Kundu, BD Moore, ...
Journal of neuro-oncology 125 (1), 133-141, 2015
182015
Medulloblastoma development: tumor biology informs treatment decisions
V Gopalakrishnan, RH Tao, T Dobson, W Brugmann, S Khatua
CNS oncology 4 (2), 79-89, 2015
162015
Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma
CP Bailey, M Figueroa, A Gangadharan, Y Yang, MM Romero, BA Kennis, ...
Neuro-oncology 22 (9), 1302-1314, 2020
152020
In Vivo 19F-Magnetic Resonance Imaging of Adoptively Transferred NK Cells
SS Somanchi, BA Kennis, V Gopalakrishnan, DA Lee, JA Bankson
Natural Killer Cells, 317-332, 2016
152016
Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines
CM Das, PE Zage, P Taylor, D Aguilera, JEA Wolff, D Lee, ...
European Journal of Cancer 46 (15), 2771-2780, 2010
142010
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20